RECRUITING

C.A.P.A.B.L.E. (Cross-Training and Physical Activity: A Better Life Experience Study)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will introduce cancer survivors to cross-training with the expectation that the program proposed will ultimately result in superior improvements in functional performance, body composition and quality of life compared with the current American Cancer Society (ACS) guidelines for cancer survivors.

Official Title

Does High-Intensity Functional Training Improve Patient Movement and Quality of Life? A Pilot Study of Cross-Training in Cancer Survivors

Quick Facts

Study Start:2018-11-12
Study Completion:2026-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03750981

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 18 years or older at time of program recruitment
  2. * Diagnosed with an invasive cancer
  3. * Cleared from their physician to participate in the program (We assume that most patients will have completed treatment, however if a patient is currently under treatment, this should be their oncologist. If the patient is not currently undergoing treatment, this could be primary care physician or oncologist).
  4. * Available transportation to and from the facility on session days
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jennifer B Beebe-Dimmer, MPH, PhD.
CONTACT
(313) 578-4209
dimmerj@karmanos.org
Tara Baird, M.Ed.
CONTACT
(313) 578-4246
bairdt@karmanos.org

Principal Investigator

Jennifer Beebe-Dimmer, MPH, PhD.
PRINCIPAL_INVESTIGATOR
Barbara Ann Karmanos Cancer Institute

Study Locations (Sites)

Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201
United States

Collaborators and Investigators

Sponsor: Barbara Ann Karmanos Cancer Institute

  • Jennifer Beebe-Dimmer, MPH, PhD., PRINCIPAL_INVESTIGATOR, Barbara Ann Karmanos Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-11-12
Study Completion Date2026-05-30

Study Record Updates

Study Start Date2018-11-12
Study Completion Date2026-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer Survivors